Abstract
Background
Our goal was to evaluate the role of breast-conservation therapy in early-stage breast cancer patients with a family history (FH) of breast cancer.
Methods
Between 1970 and 1994, 1324 female patients with breast cancer were treated with breast-conservation therapy at our institution. From these, we identified 985 patients with stage 0–II breast cancer and who had available information on FH status. FH was considered positive in any patient who had a relative who had been previously diagnosed with breast cancer. Disease-specific survival was calculated from the date of initial diagnosis using the Kaplan-Meier method.
Results
The stage distribution for the 985 patients was as follows: 0 in 65 (7%), I in 500 (51%), and II in 420 (43%). The median age was 50 years (range, 21–88), with a median follow-up time of 8.8 years (range, .25–29). The median tumor size was 1.5 cm. FH was positive in 31%. There were no significant differences in locoregional recurrence, distant recurrence, disease-specific survival, or incidence of contralateral breast cancer in patients with a positive FH versus patients with a negative FH.
Conclusions
Breast-conservation therapy is not contraindicated in early-stage breast cancer patients with a positive FH.
Similar content being viewed by others
References
Brody L, Biesecker BB. Breast cancer susceptibility genes: BrCal and BrCa2.Medicine 1998;77:208–26.
Meyn M. Ataxia telangiectasia, cancer, and the pathobiology of the ATM gene.Clin Genet 1999;55:289–304.
Kleihnes P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumor associated with p53 germiline mutations: a synopsis of 91 families.Am J Pathol 1997;150:1–13.
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis.Int J Cancer 1997;71:800–9.
Lynch HT, Watson P, Conway T, et al. Breast cancer family history as a risk factor for early onset breast cancer.Breast Cancer Res Treat 1988;11:263–7.
Chaudary MA, Millis RR, Bullbrook RD, Hayward JL. Family history and bilateral breast cancer.Breast Cancer Res Treat 1985;5:201–5.
Easton DF, Bishop DT, Ford D, the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers.Am J Hum Genet 1995;56:265–71.
Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 1989;320:822–8.
Veronesi U, Salvadori B, Luini A, et al. Conservation treatment of early breast cancer: long-term results of 1,232 cases treated with quadrantectomy, axillarry dissection, and radiotherapy.Ann Surg 1990;211:250–9.
Chappuis PO, Rosenblatt J, Foulkes WD. The influence of familial and hereditary factors on the prognosis of breast cancer.Ann Oncol 1999;10:1163–70.
McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Ductal carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy.Int J Radiat Oncol Biol Phys 1991;21:289–92.
Burke M-F, Allison R, Tripcony L. Conservative therapy of breast cancer in Queensland.Int J Radiat Oncol Biol Phys 1995;31:295–303.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;185:1457–1.
Haas JA, Schultz DJ, Peterson ME, Solin LJ. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania Experience.Cancer J Sci Am 1998;4:308–15.
Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer.J Clin Oncol 1998; 16:2045–51.
Brekelmans CTM, Voogd AC, Botke G, et al. Family history of breast cancer and local recurrence after breast-conserving therapy.Eur J Cancer 1999;35:620–6.
Chen LM, Mundt AJ, Powers C, Halpern HJ, Weichselbaum RR. Significance of family history in breast cancer treated with breast conservation therapy.Breast J 1996;2:238–45.
Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow up.Int J Radiat Oncol Biol Phys 1989;17:719–25.
Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.J Clin Oncol 1996;14:52–7.
Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications.Int J Radiat Oncol Biol Phys 1987;13:29–34.
Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy.Cancer 1989;63:1912–7.
Harrold EV, Turner BC, Marloff ET, et al. Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history.Cancer J Sci Am 1998;4:302–7.
Anderson DE, Badzioch MD. Bilaterality in familial breast cancer patients.Cancer 1985;56:2092–8.
Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.Cancer 1984;54:3002–1.
Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer.Am J Epidemiol 1992;136:937–48.
Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J. The significance of family history for patients with carcinoma of the breast.J Am Coll Surg 1994;179:29–32.
Pierce LJ, Strawderman M, Narod SA, et al. Effect of radio-therapy after breast-conserving treatment in women with breast cancer and germlineBRCA1/2 mutations.J Clin Oncol 2000; 18:3360–9.
Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.J Natl Cancer Inst 1999;91:2112–7.
Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.Lancet 2002;359:1471–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vlastos, G., Mirza, N.Q., Meric, F. et al. Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Annals of Surgical Oncology 9, 912–919 (2002). https://doi.org/10.1007/BF02557530
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02557530